Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-27

Clinical Trial Update: Primary RPLND Versus Systemic Chemotherapy in Good-prognosis Metastatic Testicular Cancer [NA]

View source ↗

Summary

This clinical trial compares primary retroperitoneal lymph node dissection (RPLND) with systemic chemotherapy as initial treatment for good-prognosis metastatic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bleomycin (bleomycin)
  • CISPLATIN (cisplatin)
  • Etoposide (Etoposide)

Snippet

Sponsor: Sahlgrenska University Hospital | Conditions: Testicular Cancer, Seminoma | NA | Status: RECRUITING